-
Notifications
You must be signed in to change notification settings - Fork 1
/
Copy pathsm.html
executable file
·196 lines (147 loc) · 11.8 KB
/
sm.html
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<title>Metabolic Syndrome :: MS</title>
<meta name="generator" content="Bootply" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
<link href="images/favicon-16x16.png" rel="shortcut icon">
<link href="css/bootstrap.min.css" rel="stylesheet">
<!--[if lt IE 9]>
<script src="//html5shim.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<link href="css/styles.css" rel="stylesheet">
<link href="css/angular-switcher.min.css" rel="stylesheet">
</head>
<body ng-app="mets" ng-controller="Idioma">
<div class="wrapper">
<div class="box">
<div class="row row-offcanvas row-offcanvas-left">
<!-- sidebar -->
<div class="column col-sm-2 col-xs-1 sidebar-offcanvas" id="sidebar">
<ul class="nav">
<li><a href="#" data-toggle="offcanvas" class="visible-xs text-center"><i class="glyphicon glyphicon-chevron-right"></i></a></li>
</ul>
<!-- Menu en Inglés -->
<div ng-if="Idioma == 'EN'">
<ul class="nav hidden-xs" id="lg-menu">
<li class="active"><a href="sm.html"><i class="glyphicon glyphicon-info-sign"></i> MS</a></li>
<li><a href="wt.html"><i class="glyphicon glyphicon-repeat"></i> WtHR</a></li>
<li><a href="ht.html"><i class="glyphicon glyphicon-heart"></i> HT</a></li>
<li><a href="vl.html"><i class="glyphicon glyphicon-ok"></i> Validation</a></li>
<li><a href="au.html"><i class="glyphicon glyphicon-user"></i> Authors</a></li>
<li><a href="ab.html"><i class="glyphicon glyphicon-edit"></i> About</a></li>
</ul>
<ul class="list-unstyled hidden-xs" id="sidebar-footer">
<li>
<h3>
<a href="http://www.uco.es" target="_blank"><img src="images/logo-footer.png" width="28px"></a>
<a href="http://imibic.org" target="_blank"><img src="images/imibic.png" width="130px"></a>
<hr><p>NIM MetS</p>
</h3> Metabolic Syndrome
</li>
</ul>
</div>
<!-- Menu en Español -->
<div ng-if="Idioma == 'ES'">
<ul class="nav hidden-xs" id="lg-menu">
<li class="active"><a href="sm.html"><i class="glyphicon glyphicon-info-sign"></i> SM</a></li>
<li><a href="wt.html"><i class="glyphicon glyphicon-repeat"></i> ICT</a></li>
<li><a href="ht.html"><i class="glyphicon glyphicon-heart"></i> HTA</a></li>
<li><a href="vl.html"><i class="glyphicon glyphicon-ok"></i> Validación</a></li>
<li><a href="au.html"><i class="glyphicon glyphicon-user"></i> Autores</a></li>
<li><a href="ab.html"><i class="glyphicon glyphicon-edit"></i> Acerca de</a></li>
</ul>
<ul class="list-unstyled hidden-xs" id="sidebar-footer">
<li>
<h3>
<a href="http://www.uco.es" target="_blank"><img src="images/logo-footer.png" width="28px"></a>
<a href="http://imibic.org" target="_blank"><img src="images/imibic.png" width="130px"></a>
<hr><p>NIM MetS</p>
</h3> Síndrome Metabólico
</li>
</ul>
</div>
<!-- tiny only nav-->
<ul class="nav visible-xs" id="xs-menu">
<li class="active"><a href="sm.html" class="text-center"><i class="glyphicon glyphicon-info-sign"></i></a></li>
<li><a href="wt.html" class="text-center"><i class="glyphicon glyphicon-repeat"></i></a></li>
<li><a href="ht.html" class="text-center"><i class="glyphicon glyphicon-heart"></i></a></li>
<li><a href="vl.html" class="text-center"><i class="glyphicon glyphicon-ok"></i></a></li>
<li><a href="au.html" class="text-center"><i class="glyphicon glyphicon-user"></i></a></li>
<li><a href="ab.html" class="text-center"><i class="glyphicon glyphicon-edit"></i></a></li>
</ul>
</div>
<!-- /sidebar -->
<!-- main right col -->
<div class="column col-sm-10 col-xs-11" id="main">
<!-- top nav -->
<div class="navbar navbar-blue navbar-static-top">
<div class="navbar-header">
<button class="navbar-toggle" type="button" data-toggle="collapse" data-target=".navbar-collapse">
<span class="sr-only">Toggle</span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
<span class="icon-bar"></span>
</button>
<img class="navbar-brand logo-lang" ng-src="images/{{Idioma}}.png" width="25px;" ng-click="cambiame()">
<a href="index.html" class="navbar-brand logo">NIM MetS</a>
</div>
</div>
<!-- /top nav -->
<div class="padding">
<div class="full col-sm-12">
<!-- content -->
<div class="row">
<!-- main col left -->
<div class="bs-callout bs-callout-info" id="callout-alerts-no-default">
<!-- Inicio en Inglés -->
<div ng-if="Idioma == 'EN'">
<h4>Metabolic Syndrome</h4>
<h5>Introduction.</h5>
<p>Metabolic syndrome (MetS) is defined as a group of metabolic risk factors, characterised by central obesity, high arterial blood pressure (BP) and an impaired glucose (hyperglycaemia) and lipid (hypertriglyceridaemia and low high-density lipoprotein (HDL)-cholesterol) metabolism.</p>
<p>MetS is closely linked to type 2 diabetes mellitus (DM), cardiovascular disease (CVD) and other cardiovascular risk factors that increase morbidity and mortality. The general increase in the prevalence of MetS over the past few decades has made it an urgent priority for public health services in all countries.</p>
<p>With the aim of the early detection of MetS, a large amount of research has been carried out recently aimed at identifying predictors based on biomarkers of metabolic risk, such as systemic inflammation markers (C-reactive protein, leukocyte rate and subtypes), adipocytokines (leptin, adiponectin, tumour necrosis factor α), uric acid and bilirubin, etc.</p>
<p>In addition, the identification of abdominal obesity and, more specifically, the accumulation of visceral fat as a key factor in the pathogenesis of insulin resistance and the onset of MetS has led to a body of research aiming to link MetS to anthropometric measurements of obesity such as body mass index (BMI), waist circumference (WC), waist–hip index, waist–height index, etc. However, the heterogeneity of the populations studied has meant that consensus and agreement in the results differ widely.</p>
<p>Occupational health nursing is actively involved in the promotion of health programmes at the workplace for the prevention of CVDs, focusing on the control of main risk factors: obesity, hypertension, hyperlipidaemia, smoking, balanced diet and physical activity.</p>
<p>The aim of this study is to propose a method for the early detection of MetS in a working population that is free of biomarkers (non-invasive) and based on anthropometric variables, and to validate it in a different population of workers.</p>
<hr>
<a href="index.html"><i class="glyphicon glyphicon-share"></i></a> Return Test
</div>
<!-- Fin en Inglés -->
<!-- Inicio en Español -->
<div ng-if="Idioma == 'ES'">
<h4>Sindrome Metabólico</h4>
<h5>Introducción.</h5>
<p>El síndrome metabólico (SM) se define como una agrupación de factores de riesgo metabólico, caracterizados por obesidad central, elevación de la presión arterial, alteraciones del metabolismo glucémico (hiperglucemia) y lipídico (hipertrigliceriemia y bajo nivel de colesterol HDL). </p>
<p>El SM está fuertemente asociado a diabetes mellitus (DM) tipo 2, enfermedades cardiovasculares (ECV), y a otros factores de riesgo cardiovascular que incrementan la morbimortalidad. El aumento generalizado de la prevalencia de SM en las últimas décadas, lo convierte en un problema de salud pública prioritario para cualquier país.</p>
<p>Con el propósito de la detección precoz de SM, recientemente, se han llevado a cabo numerosas investigaciones dirigidas a identificar variables predictoras basadas en biomarcadores de riesgo metabólico, como parámetros de inflamación sistémica (proteína C reactiva, tasa leucocitaria y subtipos), adipocitoquinas (leptina, adiponectina, el factor de necrosis tumoral α), uricemia, bilirrubina, etc.</p>
<p>Por otra parte, la identificación de la obesidad abdominal y, más concretamente, la acumulación de grasa visceral como factor clave en la etiopatogenia de la resistencia a la insulina y la aparición de SM, ha generado gran número de investigaciones con el fin de asociar SM a indicadores antropométricos de obesidad como el índice de masa corporal, la circunferencia de cintura, el índice cintura-cadera, el índice cintura-talla, etc. Sin embargo, la heterogeneidad de las poblaciones estudiadas ha provocado que el consenso y la concordancia en los resultados sean muy dispares.</p>
<p>El objetivo del presente estudio es proponer un método de detección precoz de SM en población trabajadora basado en variables antropométricas y exento de marcadores biológicos (método no invasivo), así como validarlo en una población distinta de trabajadores.</p>
<hr>
<a href="index.html"><i class="glyphicon glyphicon-share"></i></a> Volver al Test
</div>
<!-- Fin en Español -->
</div>
</div><!-- /col-9 -->
</div><!-- /padding -->
</div>
<!-- /main -->
</div>
</div>
</div>
<!-- script references -->
<!--
<script src="http://ajax.googleapis.com/ajax/libs/jquery/2.0.2/jquery.min.js"></script>
-->
<script src="js/jquery-2.2.1.min.js"></script>
<script type="text/javascript" src="angular/1.4.3/angular.min.js"></script>
<script src="js/bootstrap.min.js"></script>
<script src="js/scripts.js"></script>
<script src="js/mets.js"></script>
<script src='js/Chart.min.js'></script>
<script src='js/tc-angular-chartjs.min.js'></script>
<script src='js/angular-switcher.min.js'></script>
</body>
</html>